id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2152032,92683c5b-e7cb-4e3a-9bf0-56bca99ce957,Q2,"HOOPER, LUNDY & BOOKMAN, P.C.",401020884,"BROWN RUDNICK, LLP, ON BEHALF OF PRIME THERAPEUTICS",2018,second_quarter,PHA,H.R. 5343-Prescription Transparency Act of 2018; S. 2554-Patient Right to Know Drug Prices Act,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-07-18T18:09:20.823000-04:00